Antimicrobial activity of iodoquinol 1%-hydrocortisone acetate 2% gel against ciclopirox and clotrimazole.
Bruce P Burnett, Calvin M Mitchell
Index: Cutis. 82(4) , 273-80, (2008)
Full Text: HTML
Abstract
Commercially available topical formulations consisting of iodoquinol 1%-hydrocortisone acetate 2%, ciclopirox 0.77%, and clotrimazole 1%-betamethasone dipropionate 0.5% were assessed for their antimicrobial activity against cultures of Micrococcus luteus, Propionibacterium acnes, methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa, Corynebacterium aquaticum, Trichophyton mentagrophytes, Malassezia furfur, Microsporum canis, Candida albicans, Trichophyton rubrum, or Epidermophyton floccosum. At 1 and 5 minutes following inoculation into suspensions of each product, aliquots were removed, serially diluted, and plated onto appropriate agar to determine the log reduction in colony-forming units (CFUs) for each organism. Iodoquinol 1% produced the broadest and greatest antimicrobial activity as measured by a 3-log reduction of CFU, active against all microbes tested following incubation times of 1 or 5 minutes, except M luteus. By contrast, ciclopirox 0.77% and clotrimazole 1% showed activity against P aeruginosa and T rubrum, with ciclopirox also killing M luteus, P acnes, M canis, C albicans, and E floccosum at 5 minutes. Iodoquinol 1%-hydrocortisone acetate 2% also was the only product that showed effective antibacterial reduction of MRSA at 1 minute.
Related Compounds
Related Articles:
1995-01-01
[Nephron 69(2) , 147-50, (1995)]
2013-09-01
[Pak. J. Pharm. Sci. 26(5) , 865-71, (2013)]
2002-02-01
[J. Pharm. Biomed. Anal. 27(5) , 813-20, (2002)]
2011-03-01
[Dig. Dis. Sci. 56(3) , 677-80, (2011)]
2012-01-01
[Intern. Med. 51(5) , 471-4, (2012)]